Cite
Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis.
MLA
Bonfiglioli, Karina Rossi, et al. “Recommendations of the Brazilian Society of Rheumatology for the Use of JAK Inhibitors in the Management of Rheumatoid Arthritis.” Advances in Rheumatology (London, England), vol. 61, no. 1, Nov. 2021, p. 70. EBSCOhost, https://doi.org/10.1186/s42358-021-00228-x.
APA
Bonfiglioli, K. R., da Mota, L. M. H., de Medeiros Ribeiro, A. C., Kakehasi, A. M., Laurindo, I. M. M., Giorgi, R. D. N., Duarte, A. L. B. P., Reis, A. P. M. G., Ubirajara E Silva de Souza, M. P. G., Brenol, C. V., da Rocha Castelar Pinheiro, G., de Albuquerque, C. P., de Moura Castro, C. H., Pinto, G. L. B., Verztman, J. F., Muniz, L. F., Bertolo, M. B., da Costa Pinto, M. R., Louzada Júnior, P., … Xavier, R. M. (2021). Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis. Advances in Rheumatology (London, England), 61(1), 70. https://doi.org/10.1186/s42358-021-00228-x
Chicago
Bonfiglioli, Karina Rossi, Licia Maria Henrique da Mota, Ana Cristina de Medeiros Ribeiro, Adriana Maria Kakehasi, Ieda Maria Magalhães Laurindo, Rina Dalva Neubarth Giorgi, Angela Luzia Branco Pinto Duarte, et al. 2021. “Recommendations of the Brazilian Society of Rheumatology for the Use of JAK Inhibitors in the Management of Rheumatoid Arthritis.” Advances in Rheumatology (London, England) 61 (1): 70. doi:10.1186/s42358-021-00228-x.